Sleeping sickness parasite reveals enzyme weak spot that could guide safer drugs
African sleeping sickness and related diseases can be treated only with toxic and sometimes ineffective drugs. Now, University of Connecticut researchers show in Nucleic Acids Research that a crucial enzyme could be the key to safer, more effective medicines.
PRISM indexes and ranks — it never republishes. The full piece lives with its author on phys.org.
Read on phys.org